Skip to main content
logo
Giant Biogene Holding Co., Ltd. (HKG:2367)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
21.18
+0.78 (3.82%)
Nov 5, 2026, 4:08 PM HKT

Giant Biogene Holding Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Quarter
H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022H1 2021
Period EndingJun '26 Dec '25 Jun '25 Dec '24 Jun '24 Dec '23 Jun '23 Dec '22 Jun '22 May '21
Revenue
2,9182,4063,1132,9982,5401,9181,6061,380984.89520.6
Revenue Growth
-6.26%-19.76%22.53%56.29%58.21%39.06%63.03%-89.19%-
Gross Profit
2,3181,8912,5422,4542,0931,5961,3511,157838.25447.62
Operating Income
943.19760.711,3761,1951,086897.05714.66627.85505.29321.27
Net Income
939.71732.751,1821,079983.16784.81666.94384.96311.04289.52
Earnings Per Share
0.890.681.131.090.970.820.660.530.410.29
EPS Growth
-21.24%-37.30%16.50%33.16%46.97%53.49%59.31%-43.10%-

Cash & Debt
Chart
Fiscal Quarter
H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022H1 2021
Period EndingJun '26 Dec '25 Jun '25 Dec '24 Jun '24 Dec '23 Jun '23 Dec '22 Jun '22 May '21
Cash & Investments
7,3968,3298,8615,8786,0643,7902,7812,218--
Total Debt
12.269.696.956.711.462.732.112.59--
Net Cash (Debt)
7,3848,3198,8545,8726,0633,7872,7792,216--
Net Cash Growth
-16.61%41.68%46.05%55.04%118.16%70.92%----
Net Cash Per Share
7.007.788.445.935.993.952.762.24--

Cash Flow & CapEx
Chart
Fiscal Quarter
H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022H1 2021
Period EndingJun '26 Dec '25 Jun '25 Dec '24 Jun '24 Dec '23 Jun '23 Dec '22 Jun '22 May '21
Operating Cash Flow
789.711,065715.691,118922.79954.54692.9620.23311.41199.34
Capital Expenditures
-66.8-149.25-278.85-81.35-165.42-39.34-186.96-110.06-42.61-22.72
Free Cash Flow
722.91915.68436.841,037757.38915.2505.93510.17268.8176.62
Free Cash Flow Growth
65.49%-11.70%-42.32%13.31%49.70%79.39%88.22%-52.19%-

Margins
Chart
Fiscal Quarter
H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022H1 2021
Period EndingJun '26 Dec '25 Jun '25 Dec '24 Jun '24 Dec '23 Jun '23 Dec '22 Jun '22 May '21
Operating Margin
32.33%31.62%44.22%39.86%42.76%46.76%44.51%45.51%51.30%61.71%
Pretax Margin
37.53%37.66%46.40%43.44%45.47%50.54%48.30%48.18%52.10%65.70%
Profit Margin
32.21%30.46%37.98%35.99%38.70%40.91%41.54%27.90%31.58%55.61%
FCF Margin
24.78%38.06%14.03%34.59%29.81%47.70%31.51%36.98%27.29%33.93%

Valuation
Chart
Fiscal Quarter
H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022H1 2021
Period EndingJun '26 Dec '25 Jun '25 Dec '24 Jun '24 Dec '23 Jun '23 Dec '22 Jun '22 May '21
PE Ratio
14.5716.6424.6522.9524.3621.7329.8841.68--
Forward PE
12.1212.6120.4819.6622.1019.7122.8826.93--
P/FCF Ratio
14.8723.5637.8226.3725.7522.1930.9437.24--
PS Ratio
4.585.789.128.549.668.9510.5312.27--